Antimicrobial Effects of Biogenic Nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Infectious Diseases

Background:

• Antimicrobial resistance (AMR) is a growing global health crisis, rendering existing antibiotics ineffective.
• Multidrug-resistant (MDR) microorganisms necessitate the development of novel therapeutic strategies.
• Conventional antibiotic treatments face challenges due to resistance and the need for high doses.

Purpose of the Study:

• To review the current landscape of antibiotic treatments for infectious diseases.
• To highlight the therapeutic potential of biogenic metallic nanoparticles against MDR microorganisms.
• To explore the advantages of using nanoparticles in conjunction with conventional antibiotics.

Main Methods:

• Literature review of studies on biogenic metallic nanoparticles and their antimicrobial properties.
• Analysis of nanoparticle synthesis, characterization, and biological interactions.
• Evaluation of synergistic effects between nanoparticles and existing antimicrobial agents.

Main Results:

• Biogenic nanoparticles demonstrate significant efficacy against MDR microorganisms, both independently and synergistically with antibiotics.
• Nanoparticles are biocompatible, stable, and environmentally friendly, with modifiable capping layers.
• Functional groups on nanoparticle surfaces facilitate conjugation with therapeutic agents for enhanced delivery and efficacy.

Conclusions:

• Biogenic metallic nanoparticles represent a viable and advantageous alternative/adjunct to traditional antibiotic therapies.
• Their unique properties facilitate targeted drug delivery and improved antimicrobial activity.
• Further research into nanoparticle-based therapies is crucial for addressing the challenge of antimicrobial resistance.